High Control Human Serum |
|
35-S0013H000-L4 |
Cusabio |
10 ml |
EUR 139.2 |
|
Description: High control human Serum |
Ige Serum Laboratories manufactures the serum ige high immunotherapy reagents distributed by Genprice. The Serum Ige High Immunotherapy reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact IgE Serum. Other Serum products are available in stock. Specificity: Serum Category: Ige Group: High Immunotherapy
Mouse OVA-Specific Serum IgE ELISA Kit |
|
MyBiosource |
10x96-Strip-Wells |
EUR 3955 |
Mouse OVA-Specific Serum IgE ELISA Kit |
|
MyBiosource |
48-Strip-Wells |
EUR 305 |
Mouse OVA-Specific Serum IgE ELISA Kit |
|
MyBiosource |
5x96-Strip-Wells |
EUR 2005 |
High Immunotherapy information
PD-L1/PDCD1LG1/CD274/B7-H1 (Cancer Immunotherapy Target) |
|
MBS4380957-5x01mgWithoutBSAAzideat1mgmL |
MyBiosource |
5x0.1mg(WithoutBSA&Azideat1mg/mL) |
EUR 1725 |
PD-L1/PDCD1LG1/CD274/B7-H1 (Cancer Immunotherapy Target) |
|
MBS4380958-002mgWithBSAAzideat02mgmL |
MyBiosource |
0.02mg(WithBSA&Azideat0.2mg/mL) |
EUR 230 |
PD-L1/PDCD1LG1/CD274/B7-H1 (Cancer Immunotherapy Target) |
|
MBS4380958-01mgWithBSAAzideat02mgmL |
MyBiosource |
0.1mg(WithBSA&Azideat0.2mg/mL) |
EUR 405 |
PD-L1/PDCD1LG1/CD274/B7-H1 (Cancer Immunotherapy Target) |
|
MBS4380958-01mgWithoutBSAAzideat1mgmL |
MyBiosource |
0.1mg(WithoutBSA&Azideat1mg/mL) |
EUR 405 |
PD-L1/PDCD1LG1/CD274/B7-H1 (Cancer Immunotherapy Target) |
|
MBS4380958-5x01mgWithBSAAzideat02mgmL |
MyBiosource |
5x0.1mg(WithBSA&Azideat0.2mg/mL) |
EUR 1725 |
PD-L1/PDCD1LG1/CD274/B7-H1 (Cancer Immunotherapy Target) |
|
MBS4380958-5x01mgWithoutBSAAzideat1mgmL |
MyBiosource |
5x0.1mg(WithoutBSA&Azideat1mg/mL) |
EUR 1725 |
PD-L1/PDCD1LG1/CD274/B7-H1 (Cancer Immunotherapy Target) |
|
MBS4380959-002mgWithBSAAzideat02mgmL |
MyBiosource |
0.02mg(WithBSA&Azideat0.2mg/mL) |
EUR 230 |
PD-L1/PDCD1LG1/CD274/B7-H1 (Cancer Immunotherapy Target) |
|
MBS4380959-01mgWithBSAAzideat02mgmL |
MyBiosource |
0.1mg(WithBSA&Azideat0.2mg/mL) |
EUR 405 |
PD-L1/PDCD1LG1/CD274/B7-H1 (Cancer Immunotherapy Target) |
|
MBS4380959-01mgWithoutBSAAzideat1mgmL |
MyBiosource |
0.1mg(WithoutBSA&Azideat1mg/mL) |
EUR 405 |
PD-L1/PDCD1LG1/CD274/B7-H1 (Cancer Immunotherapy Target) |
|
MBS4380959-5x01mgWithBSAAzideat02mgmL |
MyBiosource |
5x0.1mg(WithBSA&Azideat0.2mg/mL) |
EUR 1725 |
PD-L1/PDCD1LG1/CD274/B7-H1 (Cancer Immunotherapy Target) |
|
MBS4380959-5x01mgWithoutBSAAzideat1mgmL |
MyBiosource |
5x0.1mg(WithoutBSA&Azideat1mg/mL) |
EUR 1725 |
PD-L1/PDCD1LG1/CD274/B7-H1 (Cancer Immunotherapy Target) |
|
MBS4380960-05mL |
MyBiosource |
0.5mL |
EUR 405 |
PD-L1/PDCD1LG1/CD274/B7-H1 (Cancer Immunotherapy Target) |
|
MBS4380960-5x05mL |
MyBiosource |
5x0.5mL |
EUR 1725 |
MAGE-1 (Target for Cancer Immunotherapy); Clone MA454 (Concentrate) |
|
RA0201-C.1 |
ScyTek Laboratories |
0.1 ml |
EUR 60.07 |
MAGE-1 (Target for Cancer Immunotherapy); Clone MA454 (Concentrate) |
|
RA0201-C.5 |
ScyTek Laboratories |
0.5 ml |
EUR 200.66 |
MAGE-1 (Target for Cancer Immunotherapy); Clone SPM282 (Concentrate) |
|
RA0576-C.1 |
ScyTek Laboratories |
0.1 ml |
EUR 60.07 |
MAGE-1 (Target for Cancer Immunotherapy); Clone SPM282 (Concentrate) |
|
RA0576-C.5 |
ScyTek Laboratories |
0.5 ml |
EUR 200.66 |